APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nedaplatin for Injection

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Nedaplatin for Injection Industry Growth and Trends Forecast to 2032

27 December 202576 pages

Choose your research edition.

Industry ResearchNedaplatin for Injection Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Nedaplatin for Injection Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Nedaplatin for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032174 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nedaplatin for Injection Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Nedaplatin for Injection Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Nedaplatin for Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Nedaplatin for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Nedaplatin for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Nedaplatin for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Nedaplatin for Injection include Simcere Pharmaceutical Group Limited, Qilu Pharmaceutical, Jiangsu Aosaikang Pharmaceutical Co., Ltd. and Jilin Hengjin Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Nedaplatin for Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Nedaplatin for Injection market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Nedaplatin for Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Nedaplatin for Injection.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Nedaplatin for Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Nedaplatin for Injection Market by Company

Simcere Pharmaceutical Group Limited

Qilu Pharmaceutical

Jiangsu Aosaikang Pharmaceutical Co., Ltd.

Jilin Hengjin Pharmaceutical Co., Ltd.

Nedaplatin for Injection Segment by Type

20mg

10mg

Others

Nedaplatin for Injection Segment by Application

Hospital

Clinic

Other

Nedaplatin for Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nedaplatin for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nedaplatin for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nedaplatin for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Nedaplatin for Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Nedaplatin for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 20mg Table 2. Major Company of 10mg Table 3. Major Company of Others Table 4. Global Nedaplatin for Injection Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Nedaplatin for Injection Sales by Type (2021-2026) & (K Units) Table 6. Global Nedaplatin for Injection Sales Market Share in Volume by Type (2021-2026) Table 7. Global Nedaplatin for Injection Sales by Type (2021-2026) & (US$ Million) Table 8. Global Nedaplatin for Injection Sales Market Share in Value by Type (2021-2026) Table 9. Global Nedaplatin for Injection Price by Type (2021-2026) & (US$/Unit) Table 10. Global Nedaplatin for Injection Sales by Type (2027-2032) & (K Units) Table 11. Global Nedaplatin for Injection Sales Market Share in Volume by Type (2027-2032) Table 12. Global Nedaplatin for Injection Sales by Type (2027-2032) & (US$ Million) Table 13. Global Nedaplatin for Injection Sales Market Share in Value by Type (2027-2032) Table 14. Global Nedaplatin for Injection Price by Type (2027-2032) & (US$/Unit) Table 15. North America Nedaplatin for Injection Sales by Type (2021-2026) & (K Units) Table 16. North America Nedaplatin for Injection Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Nedaplatin for Injection Sales by Type (2021-2026) & (K Units) Table 18. Europe Nedaplatin for Injection Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Nedaplatin for Injection Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Nedaplatin for Injection Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Nedaplatin for Injection Sales by Type (2021-2026) & (K Units) Table 22. Latin America Nedaplatin for Injection Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Nedaplatin for Injection Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Nedaplatin for Injection Sales by Type (2021-2026) & (US$ Million) Table 25. Nedaplatin for Injection Industry Trends Table 26. Nedaplatin for Injection Industry Drivers Table 27. Nedaplatin for Injection Industry Opportunities and Challenges Table 28. Nedaplatin for Injection Industry Restraints Table 29. Global Nedaplatin for Injection Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Nedaplatin for Injection Revenue Market Share by Company (2021-2026) Table 31. Global Nedaplatin for Injection Sales by Company (2021-2026) & (K Units) Table 32. Global Nedaplatin for Injection Sales Share by Company (2021-2026) Table 33. Global Nedaplatin for Injection Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Nedaplatin for Injection Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Nedaplatin for Injection Major Company Production Sites and Headquarters Table 36. Global Nedaplatin for Injection Company, Product Type & Application Table 37. Global Nedaplatin for Injection Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Nedaplatin for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Nedaplatin for Injection Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Nedaplatin for Injection Sales by Region (2021-2026) & (K Units) Table 42. Global Nedaplatin for Injection Sales Market Share in Volume by Region (2021-2026) Table 43. Global Nedaplatin for Injection Sales by Region (2021-2026) & (US$ Million) Table 44. Global Nedaplatin for Injection Sales Market Share in Value by Region (2021-2026) Table 45. Global Nedaplatin for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Nedaplatin for Injection Sales by Region (2027-2032) & (K Units) Table 47. Global Nedaplatin for Injection Sales Market Share in Volume by Region (2027-2032) Table 48. Global Nedaplatin for Injection Sales by Region (2027-2032) & (US$ Million) Table 49. Global Nedaplatin for Injection Sales Market Share in Value by Region (2027-2032) Table 50. Global Nedaplatin for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Nedaplatin for Injection Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Nedaplatin for Injection Sales by Application (2021-2026) & (K Units) Table 53. Global Nedaplatin for Injection Sales Market Share in Volume by Application (2021-2026) Table 54. Global Nedaplatin for Injection Sales by Application (2021-2026) & (US$ Million) Table 55. Global Nedaplatin for Injection Sales Market Share in Value by Application (2021-2026) Table 56. Global Nedaplatin for Injection Price by Application (2021-2026) & (US$/Unit) Table 57. Global Nedaplatin for Injection Sales by Application (2027-2032) & (K Units) Table 58. Global Nedaplatin for Injection Sales Market Share in Volume by Application (2027-2032) Table 59. Global Nedaplatin for Injection Sales by Application (2027-2032) & (US$ Million) Table 60. Global Nedaplatin for Injection Sales Market Share in Value by Application (2027-2032) Table 61. Global Nedaplatin for Injection Price by Application (2027-2032) & (US$/Unit) Table 62. North America Nedaplatin for Injection Sales by Application (2021-2026) & (K Units) Table 63. North America Nedaplatin for Injection Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Nedaplatin for Injection Sales by Application (2021-2026) & (K Units) Table 65. Europe Nedaplatin for Injection Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Nedaplatin for Injection Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Nedaplatin for Injection Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Nedaplatin for Injection Sales by Application (2021-2026) & (K Units) Table 69. Latin America Nedaplatin for Injection Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Nedaplatin for Injection Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Nedaplatin for Injection Sales by Application (2021-2026) & (US$ Million) Table 72. Simcere Pharmaceutical Group Limited Company Information Table 73. Simcere Pharmaceutical Group Limited Business Overview Table 74. Simcere Pharmaceutical Group Limited Nedaplatin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Simcere Pharmaceutical Group Limited Nedaplatin for Injection Product Portfolio Table 76. Simcere Pharmaceutical Group Limited Recent Development Table 77. Qilu Pharmaceutical Company Information Table 78. Qilu Pharmaceutical Business Overview Table 79. Qilu Pharmaceutical Nedaplatin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Qilu Pharmaceutical Nedaplatin for Injection Product Portfolio Table 81. Qilu Pharmaceutical Recent Development Table 82. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Company Information Table 83. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Business Overview Table 84. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Nedaplatin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Nedaplatin for Injection Product Portfolio Table 86. Jiangsu Aosaikang Pharmaceutical Co., Ltd. Recent Development Table 87. Jilin Hengjin Pharmaceutical Co., Ltd. Company Information Table 88. Jilin Hengjin Pharmaceutical Co., Ltd. Business Overview Table 89. Jilin Hengjin Pharmaceutical Co., Ltd. Nedaplatin for Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Jilin Hengjin Pharmaceutical Co., Ltd. Nedaplatin for Injection Product Portfolio Table 91. Jilin Hengjin Pharmaceutical Co., Ltd. Recent Development Table 92. North America Nedaplatin for Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 93. North America Nedaplatin for Injection Sales by Country (2021-2026) & (K Units) Table 94. North America Nedaplatin for Injection Sales Market Share by Country (2021-2026) Table 95. North America Nedaplatin for Injection Sales Forecast by Country (2027-2032) & (K Units) Table 96. North America Nedaplatin for Injection Sales Market Share Forecast by Country (2027-2032) Table 97. North America Nedaplatin for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 98. North America Nedaplatin for Injection Market Size by Country (2021-2026) & (US$ Million) Table 99. North America Nedaplatin for Injection Market Share by Country (2021-2026) Table 100. North America Nedaplatin for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 101. North America Nedaplatin for Injection Market Share Forecast by Country (2027-2032) Table 102. Europe Nedaplatin for Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 103. Europe Nedaplatin for Injection Sales by Country (2021-2026) & (K Units) Table 104. Europe Nedaplatin for Injection Sales Market Share by Country (2021-2026) Table 105. Europe Nedaplatin for Injection Sales Forecast by Country (2027-2032) & (K Units) Table 106. Europe Nedaplatin for Injection Sales Market Share Forecast by Country (2027-2032) Table 107. Europe Nedaplatin for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. Europe Nedaplatin for Injection Market Size by Country (2021-2026) & (US$ Million) Table 109. Europe Nedaplatin for Injection Market Share by Country (2021-2026) Table 110. Europe Nedaplatin for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. Europe Nedaplatin for Injection Market Share Forecast by Country (2027-2032) Table 112. Asia-Pacific Nedaplatin for Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. Asia-Pacific Nedaplatin for Injection Sales by Country (2021-2026) & (K Units) Table 114. Asia-Pacific Nedaplatin for Injection Sales Market Share by Country (2021-2026) Table 115. Asia-Pacific Nedaplatin for Injection Sales Forecast by Country (2027-2032) & (K Units) Table 116. Asia-Pacific Nedaplatin for Injection Sales Market Share Forecast by Country (2027-2032) Table 117. Asia-Pacific Nedaplatin for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Asia-Pacific Nedaplatin for Injection Market Size by Country (2021-2026) & (US$ Million) Table 119. Asia-Pacific Nedaplatin for Injection Market Share by Country (2021-2026) Table 120. Asia-Pacific Nedaplatin for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Asia-Pacific Nedaplatin for Injection Market Share Forecast by Country (2027-2032) Table 122. Latin America Nedaplatin for Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Latin America Nedaplatin for Injection Sales by Country (2021-2026) & (K Units) Table 124. Latin America Nedaplatin for Injection Sales Market Share by Country (2021-2026) Table 125. Latin America Nedaplatin for Injection Sales Forecast by Country (2027-2032) & (K Units) Table 126. Latin America Nedaplatin for Injection Sales Market Share Forecast by Country (2027-2032) Table 127. Latin America Nedaplatin for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Latin America Nedaplatin for Injection Market Size by Country (2021-2026) & (US$ Million) Table 129. Latin America Nedaplatin for Injection Market Share by Country (2021-2026) Table 130. Latin America Nedaplatin for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Latin America Nedaplatin for Injection Market Share Forecast by Country (2027-2032) Table 132. Middle East and Africa Nedaplatin for Injection Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Middle East and Africa Nedaplatin for Injection Sales by Country (2021-2026) & (K Units) Table 134. Middle East and Africa Nedaplatin for Injection Sales Market Share by Country (2021-2026) Table 135. Middle East and Africa Nedaplatin for Injection Sales Forecast by Country (2027-2032) & (K Units) Table 136. Middle East and Africa Nedaplatin for Injection Sales Market Share Forecast by Country (2027-2032) Table 137. Middle East and Africa Nedaplatin for Injection Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Middle East and Africa Nedaplatin for Injection Market Size by Country (2021-2026) & (US$ Million) Table 139. Middle East and Africa Nedaplatin for Injection Market Share by Country (2021-2026) Table 140. Middle East and Africa Nedaplatin for Injection Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Middle East and Africa Nedaplatin for Injection Market Share Forecast by Country (2027-2032) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Nedaplatin for Injection Distributors List Table 145. Nedaplatin for Injection Customers List Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Nedaplatin for Injection Image Figure 2. Global Nedaplatin for Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nedaplatin for Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Nedaplatin for Injection Sales (2021-2032) & (K Units) Figure 5. 20mg Image Figure 6. Global 20mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 10mg Image Figure 8. Global 10mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Nedaplatin for Injection Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Nedaplatin for Injection Market Share by Type 2025 VS 2032 Figure 13. North America Nedaplatin for Injection Sales Market Share in Volume by Type in 2025 Figure 14. North America Nedaplatin for Injection Sales Market Share in Value by Type in 2025 Figure 15. Europe Nedaplatin for Injection Sales Market Share in Volume by Type in 2025 Figure 16. Europe Nedaplatin for Injection Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Nedaplatin for Injection Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Nedaplatin for Injection Sales Market Share in Value by Type in 2025 Figure 19. Latin America Nedaplatin for Injection Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Nedaplatin for Injection Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Nedaplatin for Injection Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Nedaplatin for Injection Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Nedaplatin for Injection Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 27. Clinic Image Figure 28. Global Clinic Sales YoY Growth (2021-2032) & (K Units) Figure 29. Other Image Figure 30. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Nedaplatin for Injection Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Nedaplatin for Injection Market Share by Application 2025 VS 2032 Figure 33. North America Nedaplatin for Injection Sales Market Share in Volume by Application in 2025 Figure 34. North America Nedaplatin for Injection Sales Market Share in Value by Application in 2025 Figure 35. Europe Nedaplatin for Injection Sales Market Share in Volume by Application in 2025 Figure 36. Europe Nedaplatin for Injection Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Nedaplatin for Injection Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Nedaplatin for Injection Sales Market Share in Value by Application in 2025 Figure 39. Latin America Nedaplatin for Injection Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Nedaplatin for Injection Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Nedaplatin for Injection Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Nedaplatin for Injection Sales Market Share in Value by Application in 2025 Figure 43. North America Nedaplatin for Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Nedaplatin for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Nedaplatin for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Nedaplatin for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Nedaplatin for Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Nedaplatin for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Nedaplatin for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Nedaplatin for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Nedaplatin for Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Nedaplatin for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Nedaplatin for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Nedaplatin for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Nedaplatin for Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Nedaplatin for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Nedaplatin for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Nedaplatin for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Nedaplatin for Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Nedaplatin for Injection Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Nedaplatin for Injection Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Nedaplatin for Injection Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Nedaplatin for Injection Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Nedaplatin for Injection Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 20mg
  • 10mg
  • Others
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Simcere Pharmaceutical Group Limited
  • Qilu Pharmaceutical
  • Jiangsu Aosaikang Pharmaceutical Co., Ltd.
  • Jilin Hengjin Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Nedaplatin for Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Nedaplatin for Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Nedaplatin for Injection Market by Type
  6. 1.3.1 20mg
  7. 1.3.2 10mg
  8. 1.3.3 Others
  9. 1.4 Global Nedaplatin for Injection Market Size by Type
  10. 1.4.1 Global Nedaplatin for Injection Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Nedaplatin for Injection Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Nedaplatin for Injection Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Nedaplatin for Injection Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Nedaplatin for Injection Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Nedaplatin for Injection Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Nedaplatin for Injection Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Nedaplatin for Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Nedaplatin for Injection Industry Trends
  2. 2.2 Nedaplatin for Injection Industry Drivers
  3. 2.3 Nedaplatin for Injection Industry Opportunities and Challenges
  4. 2.4 Nedaplatin for Injection Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Nedaplatin for Injection Revenue (2021-2026)
  2. 3.2 Global Top Players by Nedaplatin for Injection Sales (2021-2026)
  3. 3.3 Global Top Players by Nedaplatin for Injection Price (2021-2026)
  4. 3.4 Global Nedaplatin for Injection Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Nedaplatin for Injection Major Company Production Sites & Headquarters
  6. 3.6 Global Nedaplatin for Injection Company, Product Type & Application
  7. 3.7 Global Nedaplatin for Injection Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Nedaplatin for Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Nedaplatin for Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Nedaplatin for Injection Tier 1, Tier 2, and Tier 3
4 Nedaplatin for Injection Regional Status and Outlook
  1. 4.1 Global Nedaplatin for Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Nedaplatin for Injection Historic Market Size by Region
  3. 4.2.1 Global Nedaplatin for Injection Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Nedaplatin for Injection Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Nedaplatin for Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Nedaplatin for Injection Forecasted Market Size by Region
  7. 4.3.1 Global Nedaplatin for Injection Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Nedaplatin for Injection Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Nedaplatin for Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Nedaplatin for Injection by Application
  1. 5.1 Nedaplatin for Injection Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Nedaplatin for Injection Market Size by Application
  6. 5.2.1 Global Nedaplatin for Injection Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Nedaplatin for Injection Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Nedaplatin for Injection Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Nedaplatin for Injection Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Nedaplatin for Injection Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Nedaplatin for Injection Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Nedaplatin for Injection Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Nedaplatin for Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Simcere Pharmaceutical Group Limited
  2. 6.1.1 Simcere Pharmaceutical Group Limited Company Information
  3. 6.1.2 Simcere Pharmaceutical Group Limited Business Overview
  4. 6.1.3 Simcere Pharmaceutical Group Limited Nedaplatin for Injection Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Simcere Pharmaceutical Group Limited Nedaplatin for Injection Product Portfolio
  6. 6.1.5 Simcere Pharmaceutical Group Limited Recent Developments
  7. 6.2 Qilu Pharmaceutical
  8. 6.2.1 Qilu Pharmaceutical Company Information
  9. 6.2.2 Qilu Pharmaceutical Business Overview
  10. 6.2.3 Qilu Pharmaceutical Nedaplatin for Injection Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Qilu Pharmaceutical Nedaplatin for Injection Product Portfolio
  12. 6.2.5 Qilu Pharmaceutical Recent Developments
  13. 6.3 Jiangsu Aosaikang Pharmaceutical Co., Ltd.
  14. 6.3.1 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Company Information
  15. 6.3.2 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Business Overview
  16. 6.3.3 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Nedaplatin for Injection Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Nedaplatin for Injection Product Portfolio
  18. 6.3.5 Jiangsu Aosaikang Pharmaceutical Co., Ltd. Recent Developments
  19. 6.4 Jilin Hengjin Pharmaceutical Co., Ltd.
  20. 6.4.1 Jilin Hengjin Pharmaceutical Co., Ltd. Company Information
  21. 6.4.2 Jilin Hengjin Pharmaceutical Co., Ltd. Business Overview
  22. 6.4.3 Jilin Hengjin Pharmaceutical Co., Ltd. Nedaplatin for Injection Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Jilin Hengjin Pharmaceutical Co., Ltd. Nedaplatin for Injection Product Portfolio
  24. 6.4.5 Jilin Hengjin Pharmaceutical Co., Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Nedaplatin for Injection Sales by Country
  2. 7.1.1 North America Nedaplatin for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Nedaplatin for Injection Sales by Country (2021-2026)
  4. 7.1.3 North America Nedaplatin for Injection Sales Forecast by Country (2027-2032)
  5. 7.2 North America Nedaplatin for Injection Market Size by Country
  6. 7.2.1 North America Nedaplatin for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Nedaplatin for Injection Market Size by Country (2021-2026)
  8. 7.2.3 North America Nedaplatin for Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Nedaplatin for Injection Sales by Country
  2. 8.1.1 Europe Nedaplatin for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Nedaplatin for Injection Sales by Country (2021-2026)
  4. 8.1.3 Europe Nedaplatin for Injection Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Nedaplatin for Injection Market Size by Country
  6. 8.2.1 Europe Nedaplatin for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Nedaplatin for Injection Market Size by Country (2021-2026)
  8. 8.2.3 Europe Nedaplatin for Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Nedaplatin for Injection Sales by Country
  2. 9.1.1 Asia-Pacific Nedaplatin for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Nedaplatin for Injection Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Nedaplatin for Injection Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Nedaplatin for Injection Market Size by Country
  6. 9.2.1 Asia-Pacific Nedaplatin for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Nedaplatin for Injection Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Nedaplatin for Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Nedaplatin for Injection Sales by Country
  2. 10.1.1 South America Nedaplatin for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Nedaplatin for Injection Sales by Country (2021-2026)
  4. 10.1.3 South America Nedaplatin for Injection Sales Forecast by Country (2027-2032)
  5. 10.2 South America Nedaplatin for Injection Market Size by Country
  6. 10.2.1 South America Nedaplatin for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Nedaplatin for Injection Market Size by Country (2021-2026)
  8. 10.2.3 South America Nedaplatin for Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Nedaplatin for Injection Sales by Country
  2. 11.1.1 Middle East and Africa Nedaplatin for Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Nedaplatin for Injection Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Nedaplatin for Injection Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Nedaplatin for Injection Market Size by Country
  6. 11.2.1 Middle East and Africa Nedaplatin for Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Nedaplatin for Injection Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Nedaplatin for Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Nedaplatin for Injection Value Chain Analysis
  2. 12.1.1 Nedaplatin for Injection Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Nedaplatin for Injection Production Mode & Process
  7. 12.2 Nedaplatin for Injection Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Nedaplatin for Injection Distributors
  10. 12.2.3 Nedaplatin for Injection Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst